Fmoc-L-Oic-OH

Fmoc-L-Oic-OH is an Fmoc-protected L-amino acid derivative in which the side chain corresponds to 4-hydroxyoctahydroindole (often handled as an Oic-type residue), providing a stereodefined chiral amino acid building block for peptide assembly. The molecule contains an Fmoc carbamate on the α-amino group, a free carboxylic acid for C-terminal coupling, and a side-chain hydroxyl functionality that can participate in hydrogen bonding and can be selectively derivatized when orthogonal protection is required. The presence of the chiral center at the α-position supports stereochemically controlled peptide bond formation and downstream fragment construction. The combination of a base-labile Fmoc group and a functional side-chain hydroxyl makes Fmoc-L-Oic-OH suitable for protected amino acid synthesis, iterative peptide coupling strategies, and synthetic intermediate preparation for functionalized peptidomimetics.

1. Peptide Synthesis

Fmoc-L-Oic-OH is used in solid-phase and solution-phase peptide synthesis workflows where an Fmoc-protected amino acid with a free carboxylic acid enables standard amide bond formation at the residue level. The Fmoc carbamate allows orthogonal handling of the α-amino group, while the L-configuration at the backbone supports stereochemically defined incorporation into peptide sequences. The side-chain hydroxyl can be retained for hydrogen-bonding patterning in peptide analogs or can be temporarily protected to avoid competing reactions during coupling and deprotection cycles. Downstream, the resulting peptide products can serve as research-grade scaffolds for mapping conformational effects of hydroxyl-bearing chiral residues in peptide science and peptidomimetic construction.

2. Amino Acid Derivatization

Fmoc-L-Oic-OH is applied as a chiral amino acid intermediate for side-chain functionalization strategies that exploit the hydroxyl group while maintaining a protected α-amino handle for controlled transformations. The free carboxylic acid supports conversion to activated esters or amide-forming derivatives, enabling modular derivatization routes for generating libraries of Oic-containing analogs. The Fmoc group can be used as a stable protecting-group element during selective side-chain chemistry, followed by controlled removal to expose the amine for subsequent peptide coupling or conjugation steps. The resulting functionalized amino acid derivatives can be employed to tune polarity, hydrogen-bonding capacity, and stereochemical recognition in chemical biology studies and synthetic methodology development.

3. Peptidomimetics And SAR Studies

Fmoc-L-Oic-OH supports peptidomimetic and structure-activity relationship investigations by providing a stereodefined, hydroxyl-bearing residue that can be incorporated into constrained peptide-like frameworks. The α-amino protection and C-terminal carboxyl group enable systematic replacement of native residues with an Oic-type chiral building block to probe how side-chain hydroxyl positioning influences conformation and molecular recognition. The hydroxyl functionality can participate in polar interactions in binding-site models, while the Fmoc-protected backbone facilitates stepwise synthesis of analog series for comparative SAR studies. Downstream, Oic-containing peptide analogs can be used as chemical probes or scaffold fragments in medicinal chemistry research to evaluate how stereochemistry and functional group placement affect activity trends.

4. Chemical Biology Conjugation

Fmoc-L-Oic-OH is suitable for chemical biology workflows that require controlled introduction of a chiral, hydroxyl-functional amino acid motif into larger biomolecule-reactive constructs. The Fmoc-protected amine provides a handle for sequential assembly, while the free carboxylic acid enables conversion into coupling-ready intermediates for attachment to linkers, probes, or carrier molecules. Selective side-chain hydroxyl derivatization can be used to install solubilizing groups, affinity tags, or bioorthogonal-reactive moieties depending on the conjugation design. The resulting conjugates and labeled constructs can function as analytical or mechanistic tools for studying biomolecular interactions, protein surface chemistry, or peptide-based recognition events.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-Oic-OH is used in pharmaceutical intermediate preparation where protected amino acid building blocks are required for manufacturing-compatible synthesis of peptidic or peptidomimetic intermediates. The Fmoc carbamate provides a robust α-amino protection strategy that can be removed under controlled conditions to expose the amine for subsequent coupling steps in an assembly line approach. The stereochemically defined L-amino acid core supports consistent incorporation into multistep synthetic routes, while the side-chain hydroxyl can be managed through protection or functional group transformation to match downstream process requirements. The compound's protected-amino and free-carboxyl functionality enables its conversion into activated intermediates for amide formation, supporting the preparation of defined fragments used in fine chemical synthesis and applied product development.

6. Process Chemistry Intermediate

Fmoc-L-Oic-OH is applied as a chiral process chemistry intermediate for scalable synthesis of amino acid derivatives and peptide building blocks with controlled functional group presentation. The Fmoc group serves as a stable protecting element during upstream operations, while the free carboxylic acid enables predictable activation chemistry for coupling steps in both batch and continuous fine chemical manufacturing contexts. The side-chain hydroxyl can be selectively protected or transformed to reduce side reactions and improve control over chemoselectivity during multistep sequences. Downstream, the material can be incorporated into standardized peptide-coupling sequences to generate Oic-containing intermediates and analogs used for method development, internal reference standards, and industrial-scale specialty chemical production.

1. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

2. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics